Julie Napieralski
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Safety and efficacy of fenebrutinib in relapsing multiple sclerosis (FENopta): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial and open-label extension study.
Journal: The Lancet. Neurology
Published: August 20, 2024
Pharmacy students in between pedagogical continuity and field mobilization
Journal: Actualites pharmaceutiques
Published: October 26, 2020
Ocrelizumab infusion experience in patients with relapsing and primary progressive multiple sclerosis: Results from the phase 3 randomized OPERA I, OPERA II, and ORATORIO studies.
Journal: Multiple sclerosis and related disorders
Published: November 22, 2018
Onset of clinical and MRI efficacy of ocrelizumab in relapsing multiple sclerosis.
Journal: Neurology
Published: November 05, 2018
No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: November 22, 2017
Bitopertin in Negative Symptoms of Schizophrenia-Results From the Phase III FlashLyte and DayLyte Studies.
Journal: Biological psychiatry
Published: February 25, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026